Finanzwire Finanzwire
Basculer en Français
10686 Companies
228221 Keywords
156684 Articles
120980 Press releases
Headlines Articles Press releases NanoViricides, Inc. Remove
  1. Home
  2. Companies
  3. NanoViricides, Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 04/17/2023 at 12:45, 3 years 2 months ago

    NanoViricides Has Shipped Drug Products for Impending Clinical Trials of NV-CoV-2, Its COVID Drug Candidate

    Logo of NanoViricides, Inc.
  • PRESS RELEASE

    published on 04/04/2023 at 13:45, 3 years 3 months ago

    NanoViricides Signs a License Agreement That Includes Clinical Evaluation of Its COVID-19 Drug Candidates

    Logo of NanoViricides, Inc.
  • PRESS RELEASE

    published on 02/15/2023 at 12:30, 3 years 4 months ago

    NanoViricides Has Filed its Quarterly Report - Company has Begun Production of Coronavirus Drug for Clinical Trials

    Logo of NanoViricides, Inc.
  • PRESS RELEASE

    published on 01/04/2023 at 12:35, 3 years 6 months ago

    NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in San Fransisco on January 9th at 10:30am PT

    Logo of NanoViricides, Inc.
Previous page
1 ... 19 20
Accesswire
  • Published on 07/06/2026 at 17:00, 45 minutes ago

    PPX Mining Reports Second Consecutive Monthly Historical Record of Net Profit Interest Earned at Callanquitas Mine

  • Published on 07/06/2026 at 14:30, 3 hours 15 minutes ago

    As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo

  • Published on 07/06/2026 at 14:15, 3 hours 30 minutes ago

    Gold Terra Announces C$9.7 Million Life Offering, Including Participation From Strategic Shareholder David Harquail

  • Published on 07/06/2026 at 14:15, 3 hours 30 minutes ago

    Galantas Gold Grants RSUs and Stock Options

  • Published on 07/06/2026 at 14:00, 3 hours 45 minutes ago

    Rio Grande Resources Confirms High-Grade Gold and Silver Including 46.3 g/t Gold and 1,030 g/t Silver in Channel Samples as it Advances Toward Phase 1 Drilling at its Winston Project, New Mexico

View all ACCESSWIRE
EQS Group
  • Published on 07/06/2026 at 17:27, 17 minutes ago

    EQS-Adhoc: Raiffeisen Bank International AG: RBI intends to lower the minimum acceptance threshold in the voluntary public tender offer for all Addiko shares

  • Published on 07/06/2026 at 15:05, 2 hours 39 minutes ago

    OneLayer Recognized in the Gartner® Hype Cycle™ for Private Networks for Industry, 2026

  • Published on 07/06/2026 at 15:05, 2 hours 39 minutes ago

    TMRW Vault® Receives CE Mark Under the European Medical Device Regulation (MDR)

  • Published on 07/06/2026 at 15:00, 2 hours 44 minutes ago

    Hakluyt launches the Hakluyt Essay Prize in collaboration with the Times Literary Supplement

  • Published on 07/06/2026 at 14:35, 3 hours 9 minutes ago

    Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.74 Million Tokens, and Total Crypto and Total Cash Holdings of $11.1 Billion

View all EQS
Les Echos
  • Published on 07/06/2026 at 17:40, 5 minutes ago

    Eiffage strengthens its presence in Luxembourg with the acquisition of the Baatz group’s contracting entities

  • Published on 07/06/2026 at 17:35, 10 minutes ago

    Thales - Half-year liquidity contract statement on 30 June 2026

  • Published on 07/06/2026 at 17:00, 45 minutes ago

    MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES

  • Published on 07/06/2026 at 10:59, 6 hours 45 minutes ago

    Statement of transactions in own shares from June 29, 2026 to July 3, 2026

  • Published on 07/06/2026 at 10:52, 6 hours 52 minutes ago

    voting rights

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy